SANTANDREA, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.208
NA - Nord America 1.050
EU - Europa 644
SA - Sud America 173
AF - Africa 61
OC - Oceania 11
Totale 3.147
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.008
CN - Cina 432
SG - Singapore 294
IT - Italia 239
HK - Hong Kong 161
BR - Brasile 140
GB - Regno Unito 99
VN - Vietnam 75
RU - Federazione Russa 61
KR - Corea 57
DE - Germania 56
SE - Svezia 54
ID - Indonesia 36
EG - Egitto 32
IN - India 26
IR - Iran 23
FI - Finlandia 21
MX - Messico 21
NL - Olanda 19
PK - Pakistan 19
AR - Argentina 18
FR - Francia 18
IQ - Iraq 18
CA - Canada 17
PL - Polonia 16
LT - Lituania 13
ZA - Sudafrica 13
AU - Australia 11
BD - Bangladesh 11
TR - Turchia 10
PH - Filippine 9
EC - Ecuador 8
JP - Giappone 8
UA - Ucraina 7
AT - Austria 6
ES - Italia 6
IL - Israele 6
NG - Nigeria 6
BG - Bulgaria 4
CH - Svizzera 4
CO - Colombia 4
MA - Marocco 4
MY - Malesia 4
PT - Portogallo 4
RS - Serbia 4
SA - Arabia Saudita 4
AM - Armenia 3
IE - Irlanda 3
PA - Panama 3
AE - Emirati Arabi Uniti 2
BF - Burkina Faso 2
RO - Romania 2
SN - Senegal 2
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
OM - Oman 1
PY - Paraguay 1
QA - Qatar 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.147
Salva come PNG Salva come JPEG
Città #
Santa Clara 269
Hefei 227
Ashburn 190
Singapore 181
Hong Kong 149
London 56
Beijing 46
Seoul 44
Los Angeles 38
New York 38
Chandler 35
Ho Chi Minh City 31
Milan 26
Jakarta 22
Cairo 21
Fairfield 21
Chicago 20
Nyköping 20
Shanghai 20
Buffalo 19
The Dalles 17
Kent 16
Munich 16
São Paulo 16
Moscow 15
Helsinki 14
Warsaw 14
Bologna 13
Johannesburg 11
Rome 11
Florence 9
Islamabad 9
Naples 9
Nuremberg 9
Brembate di Sopra 8
Denver 8
Salt Lake City 8
Wuhan 8
Cambridge 7
Guayaquil 7
Orem 7
Tokyo 7
Atlanta 6
Bari 6
Giza 6
Hanoi 6
Houston 6
Mexico City 6
Portsmouth 6
Redondo Beach 6
Rio de Janeiro 6
Amsterdam 5
Ann Arbor 5
Baghdad 5
Bagno a Ripoli 5
Boston 5
Brooklyn 5
Campi Bisenzio 5
Catania 5
Council Bluffs 5
Manchester 5
Migliarino 5
Montreal 5
Parma 5
San Diego 5
Seattle 5
Turku 5
Belgrade 4
Belo Horizonte 4
Bremen 4
Dallas 4
Dhaka 4
Düsseldorf 4
Lagos 4
Lauterbourg 4
Modena 4
Perth 4
Poplar 4
Porto Alegre 4
Princeton 4
Round Rock 4
Rutigliano 4
San Jose 4
Sha Tin Wai 4
Sofia 4
Songpa-gu 4
Stockholm 4
Sunderland 4
Ankara 3
Appignano 3
Austin 3
Belfast 3
Da Nang 3
Dublin 3
Elk Grove Village 3
Erbil 3
Genoa 3
Gujranwala 3
Gyeongju 3
Haiphong 3
Totale 1.966
Salva come PNG Salva come JPEG
Nome #
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists 480
Clinical Review of Mucosal Melanoma: The 11-Year Experience of a Referral Center 189
How can we treat vulvar carcinoma in pregnancy? A systematic review of the literature 165
Sinonasal NUT Carcinoma: Delayed Diagnosis Due to the COVID-19 Pandemic and a Review of the Literature 152
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 149
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 1: Focus on immunohistochemical results with discussion of pre-analytical and interpretation variables 143
Patient derived organoids are an useful tool to investigate Hippo pathway involvement in lung cancer 128
Biomarkers changes after neoadjuvant chemotherapy in breast cancer: A seven-year single institution experience 127
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling 121
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 5: Epigenetic regulation of pd-l1 118
What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. part 4: Experimental treatments in pre-clinical studies (cell lines and mouse models) 116
Clinically unquestionable but histologically deceptive melanomas in acral skin grafts: PRAME confirms its role 114
Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer 113
What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. Part 3: PD-L1, intracellular signaling pathways and tumor microenvironment 105
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 2: Clinic–pathologic correlations 103
PHD2 (EGLN1) is a novel therapeutic target in KRAS-mutated lung carcinoma 101
PRAME expression in cellular neurothekeoma: A study of 11 cases 99
Implementing an organoid platform to assess efficacy of PHD inhibitors as anti-cancer agents 94
LncRNA TAZ-AS202 promotes lung cancer progression through the regulation of the E2F1 transcription factor 93
Medullary Thyroid Carcinomas Classified According to the International Medullary Carcinoma Grading System and a Surveillance, Epidemiology, and End Results-Based Metastatic Risk Score: A Correlation With Genetic Profile and Angioinvasion 92
Digital spatial profiling for pathologists 90
null 83
A Two-Step Protocol for Isolation and Maintenance of Lung Cancer Primary 3D Cultures 62
Harnessing the hypoxia pathway to set a new therapeutic strategy for KRAS-mutated lung adenocarcinoma 59
Characterization of EGLN1 as a pro-oncogenic factor and pharmacological target in lung cancer 57
Exploring EGLN1 as a therapeutic target for KRAS mutated lung cancer 28
Totale 3.181
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.988
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.988
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/202267 11 18 0 0 2 6 3 8 2 2 8 7
2022/2023129 9 12 6 5 10 14 2 15 12 13 14 17
2023/2024442 17 17 30 40 53 40 61 42 18 48 38 38
2024/20251.233 18 41 45 100 215 175 115 65 147 53 118 141
2025/20261.300 221 157 221 295 332 74 0 0 0 0 0 0
Totale 3.181